logo

For the Inventor, By the Inventor

Danbury, CT, United States of America

Abdelhakim Hammach

This inventor holds 18 USPTO granted patents, plus 4 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdelhakim Hammach. Retrieved from https://idiyas.com/inventor/abdelhakim-hammach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0


Average Co-Inventor Count = 6.9

ph-index = 10

Forward Citations = 565(Granted Patents)


Company Filing History:

goldMedal18 out of 278 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents

Years Active: 2002-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Glucocorticoid Mimetics
Cytokine Inhibitors
Pharmaceutical Compositions
Heterocyclic Compounds
Anti-Inflammatory Agents
Benzofuran Compounds
Triazole Compounds
Tyrosine Kinase Inhibitors
Fluorinated Compounds
1,4-Disubstituted Compounds
Benzothiophene Compounds
1,4-Benzofused Urea Compounds
18 patents (USPTO):Explore Patents
1. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-06-03),
2. 7622594 - Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof (2009-11-24),
3. 7579469 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof (2009-08-25),
4. 7550461 - Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases (2009-06-23),
5. 7511042 - Triazole compounds (2009-03-31),
6. 7335657 - Cytokine inhibitors (2008-02-26),
7. 7279475 - Fluorinated di-aryl urea compounds (2007-10-09),
8. 7115644 - Heterocyclic compounds (2006-10-03),
9. 7078419 - Cytokine inhibitors (2006-07-18),
10. 7041669 - 1,4-benzofused urea compounds useful in treating cytokine mediated diseases (2006-05-09),
11. 6872726 - Fluorinated di-aryl urea compounds (2005-03-29),
12. 6852717 - Compounds useful as anti-inflammatory agents (2005-02-08),
13. 6844435 - Heterocyclic compounds useful as inhibitors of tyrosine kinases (2005-01-18),
14. 6825184 - 1,4-Disubstituted benzo-fused urea compounds (2004-11-30),
15. 6770639 - Heterocyclic compounds useful as inhibitors of tyrosine kinases (2004-08-03),

Title: Spotlight on Inventor Abdelhakim Hammach: Pioneering Pharmaceutical Innovations

Introduction:

Abdelhakim Hammach is a prolific inventor based in Danbury, CT, US, known for his groundbreaking work in the field of pharmaceuticals. With an impressive portfolio of 18 patents, Hammach has been at the forefront of developing cutting-edge solutions to treat various medical conditions.

Latest Patents:

Hammach's recent patents include innovative compounds such as Glucocorticoid mimetics, which have shown promising results in modulating the glucocorticoid receptor function to treat diseases characterized by inflammatory, allergic, or proliferative processes. These patents showcase his dedication to advancing the field of medicine through novel pharmaceutical compositions.

Career Highlights:

Currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., Abdelhakim Hammach has been instrumental in driving forward research and development initiatives at the company. His expertise and innovative approach have led to the successful creation of novel compounds aimed at improving patient outcomes and quality of life.

Collaborations:

Throughout his career, Hammach has collaborated closely with esteemed coworkers such as Neil Moss and Daniel R Goldberg. This collaborative spirit has not only fostered a culture of innovation but has also resulted in the successful development of impactful pharmaceutical solutions.

Conclusion:

Inventor Abdelhakim Hammach's dedication to creating innovative pharmaceutical solutions has solidified his reputation as a trailblazer in the field. His relentless pursuit of excellence and commitment to improving healthcare outcomes serve as an inspiration to aspiring inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…